Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain

Albertson, 2003, Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis, Crit. Care Med., 31, 419, 10.1097/01.CCM.0000045564.51812.3F Allewelt, 2000, Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread, Infect. Immun., 68, 3998, 10.1128/IAI.68.7.3998-4004.2000 Barr, 1999, The modality of Enterobacterial common antigen polysaccharide chain lengths is regulated by o349 of the wec gene cluster of Escherichia coli K-12, J. Bacteriol., 181, 6564, 10.1128/JB.181.20.6564-6568.1999 Bland, 1996, Transformations, means, and confidence intervals, BMJ, 312, 1079, 10.1136/bmj.312.7038.1079 Bridge, 2015, An Enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate, Int. J. Med. Microbiol., 305, 511, 10.1016/j.ijmm.2015.05.004 CDC, 2013 Chatfield, 1989, Live Salmonella as vaccines and carriers of foreign antigenic determinants, Vaccine, 7, 495, 10.1016/0264-410X(89)90271-5 Chatfield, 1992, Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine, Biotechnology (N Y), 10, 888 Chaudhuri, 2009, Comprehensive identification of Salmonella enterica serovar Typhimurium genes required for infection of BALB/c mice, PLoS Pathog., 5, e1000529, 10.1371/journal.ppat.1000529 DiGiandomenico, 2004, Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model, Infect. Immun., 72, 7012, 10.1128/IAI.72.12.7012-7021.2004 DiGiandomenico, 2007, Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections, Proc. Natl. Acad. Sci. U. S. A., 104, 4624, 10.1073/pnas.0608657104 Finck-Barbancon, 1997, ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury, Mol. Microbiol., 25, 547, 10.1046/j.1365-2958.1997.4891851.x Fleiszig, 1997, Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S, Infect. Immun., 65, 579, 10.1128/iai.65.2.579-586.1997 Friedman, 1982, Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants, Gene, 18, 289, 10.1016/0378-1119(82)90167-6 Galan, 1989, Virulence and vaccine potential of phoP mutants of Salmonella Typhimurium, Microb. Pathog., 6, 433, 10.1016/0882-4010(89)90085-5 Garrity-Ryan, 2000, The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages, Infect. Immun., 68, 7100, 10.1128/IAI.68.12.7100-7113.2000 Gilbreath, 2012, Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge, Infect. Immun., 80, 441, 10.1128/IAI.05559-11 Goldberg, 1992, Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli, Proc. Natl. Acad. Sci. U. S. A., 89, 10716, 10.1073/pnas.89.22.10716 Hoiseth, 1981, Aromatic-dependent Salmonella Typhimurium are non-virulent and effective as live vaccines, Nature, 291, 238, 10.1038/291238a0 Hormaeche, 1991, Immunity conferred by Aro- Salmonella live vaccines, Microb. Pathog., 10, 149, 10.1016/0882-4010(91)90075-L Iwashkiw, 2012, Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis, Microb. Cell Fact., 11, 13, 10.1186/1475-2859-11-13 Kang, 2002, Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine, Infect. Immun., 70, 1739, 10.1128/IAI.70.4.1739-1749.2002 Kong, 2008, Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment, Proc. Natl. Acad. Sci. U. S. A., 105, 9361, 10.1073/pnas.0803801105 Kong, 2012, Turning self-destructing Salmonella into a universal DNA vaccine delivery platform, Proc. Natl. Acad. Sci. U. S. A., 109, 19414, 10.1073/pnas.1217554109 Lin, 2015, Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery, Vaccines (Basel), 3, 940, 10.3390/vaccines3040940 Liu, 2011, Therapeutic efficacy of oral immunization with attenuated Salmonella Typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model, Vaccine, 29, 6679, 10.1016/j.vaccine.2011.06.099 Liu, 1973, Exotoxins of Pseudomonas aeruginosa: I. Factors that influence the production of exotoxin A, J. Infect. Dis., 128, 506, 10.1093/infdis/128.4.506 Nayak, 1998, A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae, Infect. Immun., 66, 3744, 10.1128/IAI.66.8.3744-3751.1998 Oliveira, 2012, Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice, Microbiol. Immunol., 56, 513, 10.1111/j.1348-0421.2012.00477.x Pier, 1995, Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies, Infect. Immun., 63, 2818, 10.1128/iai.63.8.2818-2825.1995 Ramos-Morales, 2003, Role for Salmonella enterica Enterobacterial common antigen in bile resistance and virulence, J. Bacteriol., 185, 5328, 10.1128/JB.185.17.5328-5332.2003 Scarff, 2008, Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice, Clin. Vaccine Immunol., 15, 367, 10.1128/CVI.00419-07 Tennant, 2011, Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains, Infect. Immun., 79, 4175, 10.1128/IAI.05278-11 Vallis, 1999, Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells, Infect. Immun., 67, 2040, 10.1128/IAI.67.4.2040-2044.1999 Valtonen, 1976, Effect of enterobacterial common antigen on mouse virulence of Salmonella Typhimurium, Infect. Immun., 13, 1601, 10.1128/iai.13.6.1601-1605.1976 Vishwakarma, 2015, Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection, Vaccine, 33, 1880, 10.1016/j.vaccine.2015.02.014 Wang, 2010, Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity, Infect. Immun., 78, 3969, 10.1128/IAI.00444-10 Wang, 2011, Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines, Infect. Immun., 79, 937, 10.1128/IAI.00445-10 Westphal, O.a.K.J., 1965. Bacterial lipopolysaccharides: Extraction with phenol-water and further applications of the procedure. Wickham, 2007, Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain, BMC Infect. Dis., 7, 65, 10.1186/1471-2334-7-65 Xin, 2009, PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae, Infect. Immun., 77, 4518, 10.1128/IAI.00486-09 Zhang, 1997, Characterization and immunogenicity of Salmonella Typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants, Infect. Immun., 65, 5381, 10.1128/iai.65.12.5381-5387.1997